Search

everythinglearnresearchcommunity

for

Search:↓

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Newly made nicotinamide compounds could potentially treat cancer.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

Trichoscopy and pathological examination both have unique benefits and cannot completely replace each other in evaluating hair.

Human TMEM2 does not break down hyaluronan but helps control its metabolism.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Latanoprost eye drops caused excessive cheek hair growth and eyelash whitening in a woman.

Bimatoprost can cause excessive eyelash growth.

The cell membrane complex in mammalian hair has three distinct types with different structures and chemical properties.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Compound 15a was effective in inhibiting 5α-reductase.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

Latanoprost eye drops caused excessive hair growth and eyelash whitening in a woman.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

Researchers successfully isolated and identified key stem cells in human hair follicles, which could help develop new skin and hair treatments.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

Minoxidil can cause skin allergy; use alternative solvents or treatments if allergic.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Minoxidil may help hair growth by stopping immune system attacks on hair follicles.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.